Back to Journals » Therapeutics and Clinical Risk Management » Volume 11

Real-world analysis of the Celgene Global Drug Safety database: early discontinuation of lenalidomide in patients with myelodysplastic syndromes due to non-serious rash

Total article views   HTML views PDF downloads Totals
17,618 Dovepress* 16,294+ 1,514 17,808
PubMed Central* 1,324 334 1,658
Totals 17,618 1,848 19,466
*Since 4 September 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 1 0 0 3 4

View citations on PubMed and Google Scholar